Versor Investments LP Increases Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

Versor Investments LP lifted its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 450.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,200 shares of the company’s stock after acquiring an additional 37,800 shares during the quarter. Versor Investments LP’s holdings in Surgery Partners were worth $978,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Principal Financial Group Inc. purchased a new stake in shares of Surgery Partners during the 3rd quarter worth approximately $1,469,000. King Street Capital Management L.P. purchased a new stake in shares of Surgery Partners during the 3rd quarter worth approximately $46,748,000. Royce & Associates LP boosted its stake in shares of Surgery Partners by 12.2% during the 3rd quarter. Royce & Associates LP now owns 510,261 shares of the company’s stock worth $16,451,000 after acquiring an additional 55,545 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Surgery Partners by 2.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock worth $60,117,000 after acquiring an additional 42,897 shares in the last quarter. Finally, Victory Capital Management Inc. boosted its stake in shares of Surgery Partners by 140.4% during the 3rd quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock worth $42,892,000 after acquiring an additional 777,038 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on SGRY. Bank of America began coverage on Surgery Partners in a research note on Monday, December 16th. They issued a “buy” rating and a $30.00 target price on the stock. JPMorgan Chase & Co. reduced their target price on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research note on Tuesday, December 3rd. Macquarie reaffirmed an “outperform” rating and issued a $34.00 target price on shares of Surgery Partners in a research note on Tuesday, November 19th. Finally, Royal Bank of Canada reduced their target price on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 20th. One analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $36.56.

Surgery Partners Trading Down 1.7 %

Shares of SGRY opened at $24.62 on Friday. The stock has a fifty day moving average of $22.88 and a two-hundred day moving average of $26.54. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The company has a market capitalization of $3.13 billion, a PE ratio of -51.29, a price-to-earnings-growth ratio of 19.21 and a beta of 2.60. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $33.97.

Insider Buying and Selling at Surgery Partners

In other news, CEO Jason Eric Evans sold 26,520 shares of the company’s stock in a transaction on Friday, February 7th. The stock was sold at an average price of $25.65, for a total transaction of $680,238.00. Following the completion of the sale, the chief executive officer now directly owns 560,698 shares in the company, valued at $14,381,903.70. This represents a 4.52 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CFO David T. Doherty sold 13,641 shares of the company’s stock in a transaction on Friday, February 7th. The stock was sold at an average price of $25.61, for a total value of $349,346.01. Following the sale, the chief financial officer now owns 108,862 shares of the company’s stock, valued at approximately $2,787,955.82. The trade was a 11.14 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 96,733 shares of company stock worth $2,480,106. Insiders own 2.30% of the company’s stock.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.